Here, we propose a simple prognostic risk model for ICI-treated metastatic cancer patients in which six peripheral blood inflammation-related parameters i.e., elevated counts of neutrophils and platelets, elevated levels of CRP, ESR and LDH and the presence of anemia were each scored with one point giving 0–6 risk points for each patient. This evidence concerns the gene CRP and anemia (phenotype).